{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:38:14Z","timestamp":1790674694957,"version":"4.1.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,15]],"date-time":"2016-05-15T00:00:00Z","timestamp":1463270400000},"content-version":"am","delay-in-days":319,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","award":["A-3340"],"award-info":[{"award-number":["A-3340"]}],"id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01NS073947"],"award-info":[{"award-number":["R01NS073947"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["NS041083-07"],"award-info":[{"award-number":["NS041083-07"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Santa Casa da Misericordia"},{"DOI":"10.13039\/100000185","name":"DARPA","doi-asserted-by":"publisher","award":["09-68-ESR-FP-010"],"award-info":[{"award-number":["09-68-ESR-FP-010"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","award":["PTDC\/SAU-TOX\/122005\/2010"],"award-info":[{"award-number":["PTDC\/SAU-TOX\/122005\/2010"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","award":["PEST-C\/SAU\/LA0001\/2013-14"],"award-info":[{"award-number":["PEST-C\/SAU\/LA0001\/2013-14"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.nbd.2015.03.030","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T11:17:26Z","timestamp":1429269446000},"page":"70-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"special_numbering":"C","title":["Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models"],"prefix":"10.1016","volume":"79","author":[{"given":"Wei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique B.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Real","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierce","family":"Payen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanguo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa E.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo R.","family":"Tom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo A.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Fan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2015.03.030_bb0005","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1750-3639.2007.00112.x","article-title":"Up-regulation of adenosine receptors in the frontal cortex in Alzheimer's disease","volume":"18","author":"Albasanz","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2015.03.030_bb0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0165-0270(01)00374-0","article-title":"The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events","volume":"108","author":"Anderson","year":"2001","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2015.03.030_bb0015","doi-asserted-by":"crossref","first-page":"11390","DOI":"10.1523\/JNEUROSCI.5817-12.2013","article-title":"Ecto-5\u2032-nucleotidase (CD73)-mediated formation of adenosine is critical for the striatal adenosine A2A receptor functions","volume":"33","author":"Augusto","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.03.030_bb0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neuroscience.2013.12.018","article-title":"Modulation of synaptic transmission by adenosine in layer 2\/3 of the rat visual cortex in vitro","volume":"260","author":"Bannon","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2015.03.030_bb0025","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/mp.2012.8","article-title":"Adenosine A2A receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation","volume":"18","author":"Batalha","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2015.03.030_bb0030","doi-asserted-by":"crossref","first-page":"22480","DOI":"10.1073\/pnas.0911503106","article-title":"Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms","volume":"106","author":"Bradford","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.03.030_bb0035","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.brainresbull.2006.02.011","article-title":"Selective extra-dimensional set shifting deficit in a knock-in mouse model of Huntington's disease","volume":"69","author":"Brooks","year":"2006","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2015.03.030_bb0040","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.brainresbull.2011.05.010","article-title":"Selective cognitive impairment in the YAC128 Huntington's disease mouse","volume":"88","author":"Brooks","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2015.03.030_bb0045","doi-asserted-by":"crossref","first-page":"14741","DOI":"10.1523\/JNEUROSCI.3728-09.2009","article-title":"Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway","volume":"29","author":"Canas","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.03.030_bb0050","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.03.030_bb0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pneurobio.2006.11.001","article-title":"The corticostriatal pathway in Huntington's disease","volume":"81","author":"Cepeda","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2015.03.030_bb0055","doi-asserted-by":"crossref","first-page":"RRN1182","DOI":"10.1371\/currents.RRN1182","article-title":"Rescuing the corticostriatal synaptic disconnection in the R6\/2 mouse model of Huntington's disease: exercise, adenosine receptors and ampakines","volume":"2","author":"Cepeda","year":"2010","journal-title":"PLoS Curr."},{"key":"10.1016\/j.nbd.2015.03.030_bb0065","doi-asserted-by":"crossref","first-page":"9192","DOI":"10.1523\/JNEUROSCI.19-21-09192.1999","article-title":"A2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice","volume":"19","author":"Chen","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.03.030_bb0070","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1093\/hmg\/ddp230","article-title":"The A2A adenosine receptor rescues the urea cycle deficiency of Huntington's disease by enhancing the activity of the ubiquitin\u2013proteasome system","volume":"18","author":"Chiang","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.03.030_bb0075","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-4159.2005.03029.x","article-title":"CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model","volume":"93","author":"Chou","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.03.030_bb0080","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1523\/JNEUROSCI.3574-05.2006","article-title":"Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1\u2013A2A receptor heteromers","volume":"26","author":"Ciruela","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.03.030_bb0085","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1471-4159.2009.06465.x","article-title":"Caffeine and an adenosine A2A receptor antagonist prevent memory impairment and synaptotoxicity in adult rats triggered by a convulsive episode in early life","volume":"112","author":"Cognato","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.03.030_bb0090","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/hmg\/ddl224","article-title":"Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease","volume":"15","author":"Cummings","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.03.030_bb0095","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuint.2007.06.026","article-title":"Different cellular sources and different roles of adenosine: A1 receptor-mediated inhibition through astrocytic-driven volume transmission and synapse-restricted A2A receptor-mediated facilitation of plasticity","volume":"52","author":"Cunha","year":"2008","journal-title":"Neurochem. Int."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2015.03.030_bb0105","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.3233\/JAD-2010-1408","article-title":"Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline","volume":"20","author":"Cunha","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2015.03.030_bb0100","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.expneurol.2007.11.013","article-title":"Adenosine A2A receptor blockade prevents memory dysfunction caused by \u03b2-amyloid peptides but not by scopolamine or MK-801","volume":"210","author":"Cunha","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.03.030_bb0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainres.2005.04.030","article-title":"Altered distribution of striatal activity-dependent synaptic plasticity in the 3-nitropropionic acid model of Huntington's disease","volume":"1047","author":"Dalbem","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2015.03.030_bb0110","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0306-4522(01)00372-4","article-title":"Inactivation of adenosine A2A receptor impairs long term potentiation in the accumbens nucleus without altering basal synaptic transmission","volume":"107","author":"d'Alcantara","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2015.03.030_bb0120","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.expneurol.2006.08.008","article-title":"Caffeine and adenosine A2a receptor antagonists prevent \u03b2-amyloid (25\u201335)-induced cognitive deficits in mice","volume":"203","author":"Dall'Igna","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.03.030_bb0125","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000322540","article-title":"Impaired long-term potentiation in the prefrontal cortex of Huntington's disease mouse models: rescue by D1 dopamine receptor activation","volume":"8","author":"Dallerac","year":"2011","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.nbd.2015.03.030_bb0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nbd.2013.08.009","article-title":"Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice","volume":"60","author":"Deng","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.03.030_bb0135","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbd.2015.03.030_bb0140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.nbd.2007.07.009","article-title":"Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6\/2 Huntington's disease mice","volume":"28","author":"Domenici","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.03.030_bb0145","doi-asserted-by":"crossref","first-page":"e21899","DOI":"10.1371\/journal.pone.0021899","article-title":"Caffeine consumption prevents diabetes-induced memory impairment and synaptotoxicity in the hippocampus of NONcZNO10\/LTJ mice","volume":"7","author":"Duarte","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2015.03.030_bb0150","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/WNL.0b013e3181eccfa2","article-title":"Mild cognitive impairment in prediagnosed Huntington disease","volume":"75","author":"Duff","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.03.030_bb0155","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuropharm.2008.04.007","article-title":"Evidence for the involvement of the adenosine A2A receptor in the lowered susceptibility to pentylenetetrazol-induced seizures produced in mice by long-term treatment with caffeine","volume":"55","author":"El Yacoubi","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2015.03.030_bb0160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00210-009-0426-8","article-title":"Adenosine A2A receptor deficient mice are partially resistant to limbic seizures","volume":"380","author":"El Yacoubi","year":"2009","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.nbd.2015.03.030_bb0165","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3233\/JAD-111982","article-title":"Caffeine consumption prevents memory impairment, neuronal damage, and adenosine A2A receptors upregulation in the hippocampus of a rat model of sporadic dementia","volume":"34","author":"Espinosa","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2015.03.030_bb0170","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1476-5381.2010.00723.x","article-title":"Adenosine-cannabinoid receptor interactions, implications for striatal function","volume":"160","author":"Ferr\u00e9","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2015.03.030_bb0175","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/nn.2216","article-title":"FGF acts as a co-transmitter through adenosine A2A receptor to regulate synaptic plasticity","volume":"11","author":"Flajolet","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2015.03.030_bb0180","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nn832","article-title":"Postsynaptic endocannabinoid release is critical to long-term depression in the striatum","volume":"5","author":"Gerdeman","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2015.03.030_bb0185","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.brainresrev.2008.12.001","article-title":"The R6 lines of transgenic mice: a model for screening new therapies for Huntington's disease","volume":"59","author":"Gil","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.nbd.2015.03.030_bb0190","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JHD-120023","article-title":"Cognitive dysfunction in Huntington's disease: humans, mouse models and molecular mechanisms","volume":"1","author":"Giralt","year":"2012","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.nbd.2015.03.030_bb0195","doi-asserted-by":"crossref","first-page":"13473","DOI":"10.1073\/pnas.93.24.13473","article-title":"Regional and cellular fractionation of working memory","volume":"93","author":"Goldman-Rakic","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.03.030_bb0200","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1021\/jo0358574","article-title":"Multigram-scale syntheses, stability, and photoreactions of A2A adenosine receptor antagonists with 8-styrylxanthine structure: potential drugs for Parkinson's disease","volume":"69","author":"Hockemeyer","year":"2004","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.nbd.2015.03.030_bb0205","doi-asserted-by":"crossref","first-page":"8986","DOI":"10.1523\/JNEUROSCI.1238-11.2011","article-title":"Behavioral and in vivo electrophysiological evidence for presymptomatic alteration of prefrontostriatal processing in the transgenic rat model for Huntington disease","volume":"31","author":"H\u00f6hn","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.03.030_bb0210","doi-asserted-by":"crossref","first-page":"e47026","DOI":"10.1371\/journal.pone.0047026","article-title":"Dysfunctional behavioral modulation of corticostriatal communication in the R6\/2 mouse model of Huntington's disease","volume":"7","author":"Hong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2015.03.030_bb0215","doi-asserted-by":"crossref","first-page":"e20934","DOI":"10.1371\/journal.pone.0020934","article-title":"A new drug design targeting the adenosinergic system for Huntington's disease","volume":"6","author":"Huang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2015.03.030_bb0220","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1523\/JNEUROSCI.5687-08.2009","article-title":"Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease","volume":"29","author":"Joshi","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.03.030_bb0225","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00213-013-3158-x","article-title":"Effects of the adenosine A2A antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex","volume":"230","author":"Kadowaki Horita","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.nbd.2015.03.030_bb0230","doi-asserted-by":"crossref","first-page":"12115","DOI":"10.1523\/JNEUROSCI.3343-09.2009","article-title":"Adenylyl cyclase type 5 contributes to corticostriatal plasticity and striatum-dependent learning","volume":"29","author":"Kheirbek","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.03.030_bb0235","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1152\/jn.2001.86.6.2667","article-title":"Electrophysiological and morphological changes in striatal spiny neurons in R6\/2 Huntington's disease transgenic mice","volume":"86","author":"Klapstein","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2015.03.030_bb0240","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.neuroscience.2007.03.036","article-title":"Dopamine-dependent long term potentiation in the dorsal striatum is reduced in the R6\/2 mouse model of Huntington's disease","volume":"146","author":"Kung","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2015.03.030_bb0245","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/brain\/121.7.1329","article-title":"Evidence for specific cognitive deficits in preclinical Huntington's disease","volume":"121","author":"Lawrence","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2015.03.030_bb0250","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.molmed.2003.08.006","article-title":"Huntington's disease: a synaptopathy?","volume":"9","author":"Li","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.nbd.2015.03.030_bb0255","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation","volume":"19","author":"Lione","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.03.030_bb0260","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/sj.bjp.0705692","article-title":"Binding of the prototypical adenosine A2A receptor agonist CGS 21680 to the cerebral cortex of adenosine A1 and A2A receptor knockout mice","volume":"141","author":"Lopes","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2015.03.030_bb0265","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.neuropharm.2010.01.008","article-title":"Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum","volume":"58","author":"Lovinger","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2015.03.030_bb0270","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2015.03.030_bb0275","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1471-4159.2010.07101.x","article-title":"Pre-synaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission","volume":"116","author":"Martire","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.03.030_bb0280","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3233\/JAD-2012-120469","article-title":"Astrocytic adenosine A2A receptors control the amyloid-\u03b2 peptide-induced decrease of glutamate uptake","volume":"31","author":"Matos","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2015.03.030_bb0285","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1523\/JNEUROSCI.4320-04.2005","article-title":"Deficits in experience-dependent cortical plasticity and sensory-discrimination learning in presymptomatic Huntington's disease mice","volume":"25","author":"Mazarakis","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.03.030_bb0290","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-6147(00)01884-8","article-title":"Mouse models of Huntington's disease","volume":"23","author":"Menalled","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2015.03.030_bb0295","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.nbd.2010.09.021","article-title":"A2A receptor knockout worsens survival and motor behaviour in a transgenic mouse model of Huntington's disease","volume":"41","author":"Mievis","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.03.030_bb0305","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tins.2010.08.002","article-title":"Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease","volume":"33","author":"Milnerwood","year":"2010","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2015.03.030_bb0300","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/hmg\/ddl092","article-title":"Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease","volume":"15","author":"Milnerwood","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.03.030_bb0310","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/nen.0b013e3180517477","article-title":"Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration","volume":"66","author":"Minghetti","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.03.030_bb0315","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1073\/pnas.0409138102","article-title":"Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades","volume":"102","author":"Nishi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.03.030_bb0320","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.euroneuro.2012.04.011","article-title":"Caffeine regulates frontocorticostriatal dopamine transporter density and improves attention and cognitive deficits in an animal model of attention deficit hyperactivity disorder","volume":"23","author":"Pandolfo","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.nbd.2015.03.030_bb0325","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bandc.2011.07.009","article-title":"Biological markers of cognition in prodromal Huntington's disease: a review","volume":"77","author":"Papp","year":"2011","journal-title":"Brain Cogn."},{"key":"10.1016\/j.nbd.2015.03.030_bb0330","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/glia.20207","article-title":"Astrocyte activation and reactive gliosis","volume":"50","author":"Pekny","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2015.03.030_bb0335","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pneurobio.2006.12.005","article-title":"Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's disease","volume":"81","author":"Popoli","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2015.03.030_bb0340","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.neurobiolaging.2004.08.012","article-title":"Caffeine reverses age-related deficits in olfactory discrimination and social recognition memory in rats. Involvement of adenosine A1 and A2A receptors","volume":"26","author":"Prediger","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2015.03.030_bb0345","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1100\/tsw.2009.143","article-title":"Key modulatory role of presynaptic adenosine A2A receptors in cortical neurotransmission to the striatal direct pathway","volume":"9","author":"Quir\u00f3z","year":"2009","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.nbd.2015.03.030_bb0350","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1152\/jn.00896.2002","article-title":"Enhanced adenosine A2A receptor facilitation of synaptic transmission in the hippocampus of aged rats","volume":"90","author":"Rebola","year":"2003","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2015.03.030_bb0355","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.neuroscience.2005.01.014","article-title":"Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat","volume":"132","author":"Rebola","year":"2005","journal-title":"Neuroscience"},{"issue":"Suppl. 5","key":"10.1016\/j.nbd.2015.03.030_bb0360","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1528-1167.2005.01026.x","article-title":"Long-term effect of convulsive behavior on the density of adenosine A1 and A2A receptors in the rat cerebral cortex","volume":"46","author":"Rebola","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2015.03.030_bb0365","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuron.2007.11.023","article-title":"Adenosine A2A receptors are essential for long-term potentiation of NMDA-EPSCs at hippocampal mossy fiber synapses","volume":"57","author":"Rebola","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2015.03.030_bb0370","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1471-4159.2011.07178.x","article-title":"Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction","volume":"117","author":"Rebola","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.03.030_bb0375","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1471-4159.2004.02887.x","article-title":"Co-localization and functional interaction between adenosine A2A and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum","volume":"92","author":"Rodrigues","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.03.030_bb0380","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.neurobiolaging.2007.03.025","article-title":"Modification of adenosine modulation of acetylcholine release in the hippocampus of aged rats","volume":"29","author":"Rodrigues","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2015.03.030_bb0385","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1212\/01.WNL.0000095205.33940.99","article-title":"Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function","volume":"61","author":"Rosin","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.03.030_bb0390","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pneurobio.2007.05.001","article-title":"Adenosine A2A receptors and basal ganglia physiology","volume":"83","author":"Schiffmann","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2015.03.030_bb0395","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1476-5381.2009.00157.x","article-title":"Triggering neurotrophic factor actions through adenosine A2A receptor activation: implications for neuroprotection","volume":"158","author":"Sebasti\u00e3o","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2015.03.030_bb0400","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0006-8993(82)90344-4","article-title":"Huntington's disease: changes in striatal proteins reflect astrocytic gliosis","volume":"245","author":"Selkoe","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2015.03.030_bb0405","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.20207","article-title":"Generalized brain and skin proteasome inhibition in Huntington's disease","volume":"56","author":"Seo","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2015.03.030_bb0415","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.1160575","article-title":"Dichotomous dopaminergic control of striatal synaptic plasticity","volume":"321","author":"Shen","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.nbd.2015.03.030_bb0410","doi-asserted-by":"crossref","first-page":"e80902","DOI":"10.1371\/journal.pone.0080902","article-title":"Adenosine A2A receptors in striatal glutamatergic terminals and GABAergic neurons oppositely modulate psychostimulant action and DARPP-32 phosphorylation","volume":"8","author":"Shen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2015.03.030_bb0420","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nbd.2013.05.013","article-title":"Association between caffeine intake and age at onset in Huntington's disease","volume":"58","author":"Simonin","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.03.030_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0020937","article-title":"Neurocognitive signs in prodromal Huntington disease","volume":"25","author":"Stout","year":"2011","journal-title":"Neuropsychology"},{"key":"10.1016\/j.nbd.2015.03.030_bb0430","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nbd.2006.01.014","article-title":"Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease","volume":"23","author":"Tarditi","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.03.030_bb0435","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1471-4159.2005.03455.x","article-title":"Adenosine A2A receptors and metabotropic glutamate 5 receptors are co-localized and functionally interact in the hippocampus: a possible key mechanism in the modulation of N-methyl-d-aspartate effects","volume":"95","author":"Tebano","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.03.030_bb0440","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.neuropharm.2007.08.006","article-title":"Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission","volume":"53","author":"Tozzi","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2015.03.030_bb0445","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbr.2009.05.006","article-title":"Rule learning, visuospatial function and motor performance in the Hdh(Q92) knock-in mouse model of Huntington's disease","volume":"203","author":"Trueman","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2015.03.030_bb0450","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2014.11.004","article-title":"Hyperactivation of D1 and A2A receptors contributes to cognitive dysfunction in Huntington's disease","volume":"74","author":"Tyebji","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.03.030_bb0455","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","article-title":"Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease","volume":"25","author":"Van Raamsdonk","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.03.030_bb0460","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1101\/lm.2136011","article-title":"Selective inactivation of adenosine A2A receptors in striatal neurons enhances working memory and reversal learning","volume":"18","author":"Wei","year":"2011","journal-title":"Learn. Mem."},{"key":"10.1016\/j.nbd.2015.03.030_bb0465","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.neuropharm.2004.01.008","article-title":"Adenosine A2A receptor-induced inhibition of NMDA and GABAA receptor-mediated synaptic currents in a subpopulation of rat striatal neurons","volume":"46","author":"Wirkner","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2015.03.030_bb0470","doi-asserted-by":"crossref","first-page":"15100","DOI":"10.1523\/JNEUROSCI.4215-09.2009","article-title":"Genetic deletion of A2A adenosine receptors in the striatum selectively impairs habit formation","volume":"29","author":"Yu","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.03.030_bb0475","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainres.2009.09.082","article-title":"Preferential enhancement of working memory in mice lacking adenosine A2A receptors","volume":"1303","author":"Zhou","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2015.03.030_bb0480","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington's disease","volume":"90","author":"Zuccato","year":"2010","journal-title":"Physiol. Rev."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115001278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115001278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T07:56:51Z","timestamp":1618905411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996115001278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":96,"alternative-id":["S0969996115001278"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2015.03.030","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2015.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}